Establishment of State-of-the-Art Methods/Techniques and Identification of Novel Biomarkers in Brain Tumor Diagnosis

Rapid progress in brain tumor diagnostics is reshaping practice across neuro-oncology. In line with the newly updated WHO classification of CNS tumors, which formalizes an integrated diagnosis that combines histopathological criteria with tumor-specific molecular signatures, current research is expanding the set of markers and tools that refine tumor recognition and classification. Parallel advances in methodology are streamlining workflows and improving diagnostic accuracy.

This Special Issue presents recent advancements and breakthroughs in brain tumor diagnosis. It focuses on the discovery and validation of novel biomarkers, the development and assessment of new diagnostic techniques, and the implementation of state-of-the-art methods for detection and classification. Content spans neuroimaging, molecular biology, pathology, and clinical diagnosis, with an emphasis on approaches that support precision diagnostics and inform treatment selection.